rs267606603
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1_ModeratePM2PP3_StrongPP5_Very_Strong
The NM_001042492.3(NF1):c.1260+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000066 in 151,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001042492.3 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.1260+1G>A | splice_donor_variant | ENST00000358273.9 | |||
NF1 | NM_000267.3 | c.1260+1G>A | splice_donor_variant | ||||
NF1 | NM_001128147.3 | c.1260+1G>A | splice_donor_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.1260+1G>A | splice_donor_variant | 1 | NM_001042492.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000660 AC: 1AN: 151456Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome ? AF: 0.00000660 AC: 1AN: 151456Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73900
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Sep 30, 2023 | This sequence change affects a donor splice site in intron 11 of the NF1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with neurofibromatosis type 1 (PMID: 10677298, 22155606; Invitae). ClinVar contains an entry for this variant (Variation ID: 356). Studies have shown that disruption of this splice site results in inclusion of 13 base pairs of intronic sequence and introduces a premature termination codon (PMID: 10677298). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Mar 15, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 17, 2020 | Canonical splice site variant demonstrated to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease (Eisenbarth 2000, Giugliano 2019); Not observed in large population cohorts (Lek 2016); Observed in individuals with clinically diagnosed neurofibromatosis type 1 referred for genetic testing at GeneDx and in published literature (Eisenbarth 2000, Maertens 2006, Giugliano 2019); This variant is associated with the following publications: (PMID: 31370276, 16941471, 10677298, 11409870, 22155606, 28492532, 23913538, 10712197, 25525159) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at